ngenol derivatives inhibit proliferation and induce apoptosis in breast cancer cell lines

We present an analysis of the antitumour effects of a library of ingenol derivatives synthesized in our laboratory and published elsewhere. Fluoro-ingenol (1), ingenol-20-deoxy-20-phtalimido (2), ingenol-3-benzoate-20-deoxy-20-benzamide (3), ingenol-3-benzoate (4), ingenol-3,5-dibenzoate (5), ingenol-3,20-dibenzoate (6), 20-deoxy-20-benylureidoingenol-3-benzoate (7), ingenol-20-deoxy-20-fluoro-3-benzoate (8), ingenol-20-deoxy-20-fluoro-3,5-dibenzoate (9), ingenol-20-phenylcarbamate (10), ingenol-20-benzoate (11), ingenol-3-benzoate-20-phenylcarbamate (12) were tested in vitro on two well characterized breast cancer cell (BCC) lines, namely T47D and MDA-MB-231, as representative of two opposite types of hormone-sensitiveness and differentiation stage. These experiments led us to identify ingenol-20-benzoate (11) as a promising antitumour compound characterized by a relevant inhibition of cell growth and apoptotic cell death involving a p53-mediated pathway.

Apoptosis; Breast cancer; Chemotherapy; Ingenol; PKC

[1] Zechmeister K., Brandl F., Hoppe W., Hecker E., Opferkuch H.J., Adolf W.: "Structure determination of new tetraacyclic diterpene ingenol triacetate with triple product methods". Tetrahedron Letters, 1970, 47, 4075.

[2] Nishizuka Y.: "Studies and perspectives of protein kinase C" Science, 1986, 233, 305.

[3] Mbwambo Z.H., Lee S.K., Mshiu E.N., Pezzuto J.M., Kinghorn A.O.: "Constituents from the stem wood of Euphorbia quinquecostata with phorbol dibutyrate receptor-binding inhibitory activity". J. Nat. Prod., 1996, 59, 1051.

[4] Kupchan S.M., Uchida I., Branfman A.R., Dailey R.G. Jr., Fei B.Y.: "Antileukemic principles isolated from euphorbiaceae plants". Science, 1976, 191, 571.

[5] ltokawa H., Ichihara Y., Watanabe K., Takeya K.: "An antitumour principle from Euphorbia lathyris". Planta Med., 1989, 55, 271.

[6] Fujiwara M., Ijichi K., Katsuura K., Wang G.Y.S., Uemura D. et al.: "Ingenol derivatives are highly potent and selective inhibitors of HIV replication in vitro". Antiviral Chem. Chemother., 1996, 7, 230.

[7] Nakamura H., Kishi Y., Pa」ares M.A., Rando R.R.: "Structural basis of protein kinase C activation by tumour promoters". Proc Natl. Acad. Sci USA, 1989, 86, 9672.

[8] Appendino G., Tron G.C., Cravotto G., Palmisano G., Annunziata R., Baj G. et al.: "Synthesis of modified ingenol esters". Eur. J. Organic Chem., 1999, 12, 3413.

[9] Kelsey J.L., Bernstein L.: "Epidemiology and prevention of breast cancer". Ann. Rev. Public Health., 1996, 17, 47.

[10] Gibbs J.B.: "Mechanism-based target identification and drug discovery in cancer research". Science, 2000, 287, 1969.

[11] Baj G., Arnulfo A., Deaglio S., Mallone R., Vigone A., Rosa M. et al.: "Retinoids in breast cancer prevention and treatment. A review of the literature". Eur. J. Gynaecol. Oncol., 2000, 21, 411.

[12] Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P. et al.: "Features of apoptotic cells measured by flow cytometry". Cytometry, 1992, 13, 795.

[13] Ahmed S.A., Gogal R.M. Jr., Walsh J.E.: "A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to[3H]thymidine incorporation assay". J. lmmunol. Methods, 1994, 170, 211.

[14] Nociari M.M., Shalev A., Benias P., Russo C.: "A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity". J. lmmunol. Methods, 1998, 213, 157.

[15] Deaglio S., Mallone R., Baj G., Donati D., Giraudo G., Como F. et al.: "Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway". FASEB J., 2001, 15, 580.

[16] Baj G., Arnulfo A., Deaglio S., Mallone R., Vigone A., De Cesaries M.G. et al.: "Arsenic trioxide and breast cancer. Analysis of the apoptotic differentiative and irnrnunornodulatory effects". Breast Cancer Res. Treat., 2002, 73, 61.

[17] Zhang G.C., Kazanietz M.G., Blumberg P.M., Hurley J.H.: "Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester". Cell, 1995, 81, 917.